CMV retinitis: Difference between revisions

Line 17: Line 17:


==Treatment==
==Treatment==
===Antivirals===
{{CMV retinitis treatment}}
{{CMV retinitis treatment}}



Revision as of 15:46, 29 April 2015

Background

  • Most frequent and serious ocular OI
  • Leading cause of blindness in AIDS pts
  • Typically occurs with CD4 less than 50

Diagnosis

Fundus photograph of CMV retinitis
  • Signs/symptoms are variable; may include:
    • Change in visual acuity
    • Visual field cuts (Scotomas, loss of central vision)
    • Floaters, flashing lights
    • Photophobia
    • Eye redness/pain

Differential Diagnosis

Acute onset flashers and floaters

Treatment

Antivirals

Severe Vision Threatening

  • Ganciclovir intraocular implant for 8 months AND
    • Valganciclovir 900mg PO q12hrs x 14 days FOLLOWED BY 900mg PO q24hrs x 7 days

Peripheral lesions

  • Valganciclovir 900mg PO q12hrs x 21 days FOLLOWED BY 900mg PO q24hrs x 7 days

Complications

  • Retinal detachment
  • Complete Vision loss
  • CMV Immune Recovery Uveitis (IRU)
    • Patients with retinitis who develop blurry vision after starting HART need ophtho eval to assess for CMV progression, relapse, or IRU
    • Possible cause - T-cell mediated immune reconstitution to latent CMV intraocular antigens
    • Symptoms - Floaters, photophobia, blurred vision
    • Occurs median 20 weeks after starting HART
    • Urgent ophtho eval

See Also

Source

  • Tintinalli
  • UpToDate - "Pathogenesis, clinical manifestations, and diagnosis of AIDS-related cytomegalovirus retinitis"